Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Watch
Primary summary from verified readiness
- Confidence
- 85% · fresh
- Computed at
- 2026-10-29T16:46:08.98172+00:00
- Claimed
- 45
- Reported
- 45
- Verified
- 42
- Gap
- +3
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Critical
Decision
What the current evidence supports
Human editorial judgment · 2026-10-29
Track; not yet
- Why
- The evidence is strong on momentum and weak on proof. The company has an RMB 700M raise, a Class III registration trial across about 20 tertiary hospitals led by Huashan Hospital, and entry into the NMPA innovative-device special review (the Chinese regulator's priority review channel). Most performance figures (96.1% and 91.2% decoding accuracy, under 50 ms latency, 5.2 bits per second) come from the company or its press releases, and the sample is only dozens of cases by the account of a quoted founder. No approval has been reported, and no trial enrollment size, endpoints or independent safety data appear in the sources reviewed.
- Next
- Watch for disclosure of the registration trial's enrollment and endpoints, NMPA Class III approval, results from the 15 to 20 sites, and whether the Jiangxi factory reaches production.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 10
- Tier 1
- 1
- Tier 2
- 9
- Tier 3
- 0
- Supports
- 5
- Contradicts
- 1
- Context
- 4
- Latest observed
- 2026-10-28
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-10-29 Initial recorded band: watch.